Profile data is unavailable for this security.
About the company
Guangzhou LBP Medicine Science & Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. The Company’s main products are pathological diagnostic reagents and instruments, covering three major technology platforms for cytological diagnosis, molecular diagnosis and immunodiagnosis, including LBP series, IHC series, PCR series and FISH series, such as integrated slide and dyeing machine, liquid-based cell and microorganism processing, preservation reagents, automatic nucleic acid molecular hybridization instrument, automatic slide processing system and immunochromogenic reagents, etc. Its products are mainly used in pathological diagnosis of tumors. The Company operates its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)371.03m
- Net income in CNY-19.11m
- Incorporated2005
- Employees796.00
- LocationGuangzhou LBP Medicine Science & Technology Co LtdNo. 2, Kexin Street, Fengxin RoadScience City, Huangpu DistrictGUANGZHOU 510663ChinaCHN
- Phone+86 2 032210051
- Fax+86 2 032290284
- Websitehttps://www.gzlbp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Suzhou Iron Technology Co Ltd | 381.50m | 5.23m | 2.11bn | 680.00 | 346.59 | 2.72 | -- | 5.54 | 0.079 | 0.079 | 5.10 | 10.06 | 0.2822 | 2.23 | 1.50 | -- | 0.4366 | 4.75 | 0.7154 | 7.34 | 43.10 | 53.91 | 1.55 | 14.71 | 1.20 | 1.29 | 0.2133 | 31.78 | -10.52 | 2.22 | -173.52 | -- | -- | -- |
| Shanghai Rendu Biotechnology Co Ltd | 165.86m | -5.47m | 2.14bn | 335.00 | -- | 2.33 | -- | 12.92 | -0.1374 | -0.1374 | 4.14 | 22.92 | 0.1662 | 1.62 | 2.93 | 495,112.60 | -0.5482 | 4.37 | -0.5875 | 4.91 | 76.46 | 73.71 | -3.30 | 12.61 | 13.50 | -- | 0.0047 | 11.16 | 7.87 | 12.33 | -194.59 | -- | -28.11 | -- |
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 371.03m | -19.11m | 2.59bn | 796.00 | -- | 2.11 | -- | 6.98 | -0.2042 | -0.2042 | 3.97 | 13.10 | 0.2761 | 1.55 | 1.71 | 466,121.80 | -1.49 | 3.50 | -1.55 | 3.78 | 63.03 | 72.02 | -5.41 | 9.79 | 7.80 | -- | 0.0118 | 32.69 | -5.33 | 5.80 | -46.85 | -22.05 | -7.83 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 566.02m | 79.32m | 2.61bn | 1.08k | 34.71 | 2.11 | -- | 4.62 | 0.5367 | 0.5367 | 3.75 | 8.81 | 0.335 | 2.65 | 4.37 | 523,125.40 | 4.81 | 7.56 | 5.10 | 8.33 | 41.07 | 36.85 | 14.35 | 16.26 | 6.46 | 9.35 | 0.2334 | 21.03 | 20.63 | 17.68 | 107.51 | 1.76 | 14.94 | -27.21 |
| Jiangsu Cowin Biotech Co Ltd | 167.17m | -137.72m | 2.77bn | 833.00 | -- | 1.99 | -- | 16.59 | -1.24 | -1.24 | 1.51 | 12.36 | 0.1038 | 1.81 | 2.52 | 200,679.40 | -8.91 | 2.79 | -9.42 | 2.97 | 45.15 | 68.50 | -85.88 | 11.47 | 13.54 | -- | 0.0156 | 32.07 | -26.54 | 11.23 | -86.25 | -- | 34.36 | -- |
| Maider Medical Industry Equipment Co Ltd | 279.92m | -18.77m | 2.90bn | 657.00 | -- | 3.60 | -- | 10.35 | -0.1053 | -0.1053 | 1.68 | 4.85 | 0.249 | 1.07 | 2.08 | 426,058.40 | -3.34 | 5.79 | -4.30 | 6.86 | 34.68 | 49.32 | -13.40 | 16.23 | 1.91 | -- | 0.0705 | 63.92 | -42.77 | 5.58 | -120.02 | -- | 22.08 | -- |
| Jinan High-tech Development Co Ltd | 324.74m | -841.90m | 2.95bn | 565.00 | -- | 67.35 | -- | 9.10 | -1.03 | -1.03 | 0.3748 | 0.0496 | 0.142 | 0.4155 | 0.8567 | 574,762.40 | -39.48 | -8.01 | -161.56 | -27.24 | 16.82 | 28.09 | -277.95 | -31.77 | 0.8954 | -- | 0.283 | -- | -48.02 | -26.91 | -747.31 | -- | -48.67 | -- |
| Shanghai General Hthy Info & Tech Co Ltd | 393.61m | 8.92m | 3.02bn | 355.00 | 345.04 | 2.80 | -- | 7.67 | 0.0644 | 0.0644 | 2.89 | 7.94 | 0.2601 | 3.05 | 0.7735 | 1,108,747.00 | 0.6908 | 7.98 | 0.9681 | 10.00 | 29.15 | 50.08 | 2.66 | 26.00 | 1.82 | 4.30 | 0.1357 | 15.97 | 3.51 | 1.18 | -45.80 | -18.76 | 7.19 | -- |
| Chemclin Diagnostics Co Ltd | 353.33m | 56.49m | 3.10bn | 629.00 | 54.88 | 2.20 | -- | 8.76 | 0.1407 | 0.1407 | 0.8799 | 3.51 | 0.1957 | 1.06 | 16.07 | 561,724.90 | 3.13 | 9.46 | 3.44 | 10.57 | 66.36 | 73.98 | 15.99 | 30.72 | 6.62 | -- | 0.1472 | 44.55 | -2.03 | -0.8218 | -13.77 | -2.00 | 14.24 | -- |
| Kontour XiAn Medical Technology Co Ltd | 332.92m | 88.40m | 3.16bn | 311.00 | 35.78 | 4.60 | -- | 9.50 | 1.09 | 1.09 | 4.10 | 8.47 | 0.4356 | 2.73 | 38.35 | 1,070,470.00 | 11.45 | 13.82 | 12.97 | 15.72 | 77.13 | 79.18 | 26.29 | 30.37 | 4.51 | 8.00 | 0.0595 | 28.58 | 17.06 | 16.85 | 17.07 | 11.22 | 37.93 | -- |
Data as of Feb 13 2026. Currency figures normalised to Guangzhou LBP Medicine Science & Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2025 | 850.00k | 4.01% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 288.29k | 1.36% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 182.80k | 0.86% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 87.17k | 0.41% |
| Beixin Ruifeng Fund Management Co., Ltd.as of 30 Jun 2025 | 80.00k | 0.38% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 75.94k | 0.36% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2025 | 73.35k | 0.35% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 57.51k | 0.27% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 40.00k | 0.19% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 39.12k | 0.19% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
